Navigation Links
Lung Cancer Alliance Calls American Cancer Society's Claim of Progress Selective
Date:5/29/2009

WASHINGTON, May 29 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) said that the American Cancer Society's claim of "progress in cancer fight" earlier this week was based on "selective culling of statistics and ignores the dismal truth that we have made very little progress on the most lethal cancers, including lung cancer, which causes one in every two cancer deaths, or in metastatic cancer of any kind."

(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO)

LCA President & CEO Laurie Fenton Ambrose agreed that progress has been made with certain cancers such as breast, prostate and colon which have widely accepted screening tests for early detection and ACS deserves credit for promulgating information to the public on the importance of these tests.

"But this is not time to be celebrating when half of all cancers still have survival rates of less than 50% and when we are facing a 45% increase in the overall number of new cancer cases by the year 2030," she said, citing a recent report on the upcoming tidal wave in the Journal of Clinical Oncology.

"There could be no stronger wake-up call," she said. "We can't continue to tout selected changes in incidence and mortality rates over a limited number of cancers over a limited period of time. We have to step back and look at the big picture and try to figure out why we have not done better and where we have to go from here."

In 1975 when the so-called War on Cancer was launched, the incidence rate (the number of men and women with cancer for each 100,000 of population) was 400.4. In 2006, the rate was 456.2. The death rate in 1975 was 199.1. In 2006 it was 187.0. The explanation for why the death rate has fallen depends on the type of cancer, levels of respective research funding, behavior modifications, and the deployment and awar
'/>"/>

SOURCE Lung Cancer Alliance
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SOUTHFIELD, Mich., Dec. 1 /PRNewswire-First...SE: FMR ) ("First Mercury" or the "Company") ann...f Directors declared a quarterly cash dividend of ...shareholders of record at the close of business on...inancial Corporation ,, First Mercury Financia...
(Date:12/1/2009)... identify those who would benefit from liver surge...Y, Dec. 1 (HealthDay News) -- A CT scan of liver t...y help predict overall survival after chemotherapy...stin) to cytotoxic chemotherapy has been shown to ...ectal cancer and to produce better results in pati...
(Date:12/1/2009)...LADELPHIA (December 1, 2009) Wistar Institute re... Pennsylvania and New York University have identif...ate early-stage lung tumors in people at high risk...ed online December 1 in Cancer Research , a journ..., could lead to a simple blood test to detect lung...
(Date:12/1/2009)... Ever thought you could quit s...vin Arthur Smith,s groundbreaking new system for q...ermanent. In just twenty eight days your cravings ... (PRWEB) December 1, 2009 -...g her eight-year addiction to nicotine, smoking at...
(Date:12/1/2009)... , LEHIGH VALLEY, Pa., Dec. 1 /PRNewswire-Firs...t has completed the previously announced sale of t...s, marketed under the Airthane® and Versathan... subsidiary of global polyurethane chemicals produ...Products, manufacturing facility in Paulsboro, N.J...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2
...,Corporation (Nasdaq: SMTS ) announced today that... to repurchase up to $15 million of its common,sha...e open market or in,privately negotiated transacti...186 common shares outstanding as of April,2, 2008....
... for lung invasion, study shows , , THURSD...nd to spread to specific tissues, and now research...pens. , Working with breast tumors, Joan Massague,...ling "relay" that enables the cancer to molecularl...
...b &,Ellis Company (NYSE: GBE ), a leading real es...report released today that aging baby boomers and,...fuel demand for,healthcare properties over the nex...llis, Chief Economist and author of the,report., ...
...roviders, and Patients, WASHINGTON, April 3, 2008...rganizations (AAPPO), in collaboration,with DMAA: ... a diabetes,toolkit for PPO executives to help hea...: http://www.newscom.com/cgi-bin/prnh/20060126/CL...
...n A. Clements is the recipient of the 2008 Pollin ...to our understanding of how lungs hold air, and to...piratory distress syndrome (RDS) in infants. Once ...t international award for pediatric research, reco...
...a Hall Institute, Professor Suzanne Cory, is one o...omson Scientific Citation Awards announced at the ...tific, a US-based international information analys...per their published research has had over a period...
Other Medicine News:Health News:Somanetics Announces Share Repurchase Program 2Health News:Molecular Cause of Breast Cancer Metastasis Discovered 2Health News:Molecular Cause of Breast Cancer Metastasis Discovered 3Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 2Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 3Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 4Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 5Health News:AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care 2Health News:AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 2Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 4Health News:Professor Suzanne Cory honored with national citation award 2
(Date:12/1/2009)...BUQUERQUE, N.M., Dec. 1 Exagen Dia... that discovers, develops and markets proprietary ...Scott Glenn as chairman of the company,s board of ... to joining Exagen, Glenn was managing partner of ... of successful biomedical companies including Prom...
(Date:12/1/2009)..., BEIJING, Dec. 1 /PRNewswire-Asia/ -- Sino...r of biopharmaceutical products in China, announce...rder for its H1N1 vaccine, PANFLU.1(TM),from Chin...y for the national,purchase plan. Under this purch...ional one million doses of PANFLU.1 (TM) (15ug/0.5...
(Date:12/1/2009)..., REDWOOD CITY, Calif., Dec. 1 Cod...ationship and the signing of its second agreement ..., the world,s largest generic drug manufacturer. ...eutical products. Codexis announced an earlier ag...w agreement, Teva will use Codexis biocatalysis te...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Codexis Expands Collaboration with Teva 2Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 1Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 2Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 3Web Is Becoming One Stop Shopping for Health Help 54591 1Web Is Becoming One Stop Shopping for Health Help 54591 2Web Is Becoming One Stop Shopping for Health Help 54591 3
...s of Arimidex (anastrozole) over tamoxifen at prev...crease over time - even four years after ...ec. 14 New data from ATAC*, one of the,world,s la...l women with,early breast cancer, reinforce that a...ee, for longer. For the first time, anastrozole ha...
...ON, Mass., Dec. 18 Alseres,Pharmaceuticals, Inc.,...olled,the first subject in the initial stage of th... (POET-2) Phase III clinical trial program. This,s...Birmingham trial site,under the direction of Princ...nd Chairman of the Department of Neurology., ALTR...
Other Medicine Technology:Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 2Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 3Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 4Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 5Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: